ONE Gas Heads Into Earnings With Options at Their Most Defensive
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
OGS reports Q3 2026 results on November 3 with options traders taking their most defensive stance of the past year, even as the stock itself has rallied hard into the print.
The clearest pre-earnings signal is in the options market. The put/call ratio hit 1.06 on November 2, its highest reading of the last 52 weeks, nearly 1.8 standard deviations above the 20-day average of 0.56. That jump has come quickly: the PCR was below 0.25 as recently as mid-October, before more than quadrupling into the report date. The hedging demand stands in contrast to price action that has been firmly positive. OGS is up 10% over the past month and 2% on the week, closing at $79.94 on Monday.
Short interest adds a separate layer of caution worth noting. At 8% of the free float, short positioning is meaningful and has climbed roughly 22% over the past month, with the bulk of that increase arriving after October 8. Days to cover, per FINRA's most recent fortnightly data, run at 6.9, indicating shorts would need almost a full week's average volume to exit. Despite that build, the borrow market remains relaxed: availability is ample at 1,411%, meaning shares to borrow far outnumber those already lent, and borrowing costs are low at 0.52%, even though that rate has risen about 21% over the past week as short demand has ticked up.
Analysts are divided, and the direction of recent moves leans cautious. Jefferies downgraded OGS to Hold from Buy on October 8, cutting its target sharply from $103 to $80, a signal that at least one formerly bullish voice sees the risk/reward as much tighter at current prices. Morgan Stanley has trimmed its target twice in two months, most recently from $79 to $78 last week, maintaining Equal-Weight throughout. Against that, Scotiabank initiated coverage with a Sector Outperform rating and an $86 target in late September, and the consensus mean price target of $85 leaves about 6% upside from Monday's close. Bulls point to cold-weather demand, regulatory momentum and potential new housing growth; bears flag the company's geographic concentration across Oklahoma, Kansas and Texas and the long-term risk of shifting energy preferences in those markets. The stock's dividend score ranks in the 96th percentile, a draw for income-focused holders, but EPS momentum over the past 30 and 90 days sits well below average at the 19th and 32nd percentiles respectively.
On the ownership side, BlackRock filed a Schedule 13G/A on October 27, raising its stake to 13.8% from 12.8%, a fresh signal that the largest passive holder added into the recent rally. State Street and American Century also added shares in the last reported quarter. The Vanguard Group filed to show its direct stake had fallen to zero in March, though two Vanguard-affiliated entities (Vanguard Portfolio Management and Vanguard Capital Management) each filed 5%-plus positions in April, suggesting a restructuring of that ownership rather than an exit. Wikipedia attention spiked to a z-score of 2.8 relative to OGS's own recent history as of October 23, pointing to a pickup in retail interest that coincides with the stock's sharp one-month rally.
The print will test whether OGS's operational performance and regulatory outlook can justify a valuation that, at 16x trailing earnings and with the put/call ratio at a year high, the market is treating with increasing caution even as it bids the shares higher.
Stocks in this article
See the live data behind this article on ORTEX.
Open OGS on ORTEX →How this article was generated
- Generated
- 3 Nov 2026, 05:42
- Data as of
- 3 Nov 2026, 04:47
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.